The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American heart …, 2012 - Elsevier
BACKGROUND: The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …
被引用次数：66 相关文章

The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic …

S BANSILAL, ME FARKOUH, W HUEB… - American Heart …, 2012 - observatorio.fm.usp.br
Background The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American Heart …, 2012 - europepmc.org
Background The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American Heart …, 2012 - infona.pl
The optimal revascularization strategy for diabetic patients with multivessel coronary artery
disease (MVD) remains uncertain for lack of an adequately powered, randomized trial. The …

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic …

S Bansilal, ME Farkouh, W Hueb, M Ogdie, G Dangas… - 2012 - pubmed.ncbi.nlm.nih.gov
Background The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

[引用][C] The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and …

S BANSILAL, ME FARKOUH… - The American heart …, 2012 - pascal-francis.inist.fr
The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal
management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at …

[引用][C] The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American Heart …, 2012 - cir.nii.ac.jp
The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal
management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study …
[PDF] academia.edu

[PDF][PDF] The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American Heart …, 2012 - academia.edu
Background The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …
[PDF] academia.edu

[PDF][PDF] The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American Heart …, 2012 - academia.edu
Background The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

[引用][C] The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - The American Heart …, 2012 - Elsevier Limited